Skip to main content Skip to footer

Press Releases

Bringing Science to Society™

Investors

Investors

  • Overview
  • Press Releases
  • Investor Events
  • Presentations
  • Governance
    • Governance Documents
    • Management Team
    • Board of Directors
    • Board Committees
  • Stock Information
    • Quote
    • Analyst Coverage
  • Financials & Filings
    • SEC Filings
Jun 16, 2017 7:00am EDT

Recro Pharma to Participate in Hospital Drug Launch Panel at the JMP Life Sciences Conference

Jun 15, 2017 7:00am EDT

Recro Pharma Reports Inducement Grants for New Staff

Jun 06, 2017 7:00am EDT

Recro Pharma Appoints Ryan D. Lake as Senior Vice President of Finance and Chief Accounting Officer

Jun 02, 2017 7:00am EDT

Recro Pharma to Participate in Upcoming Investor Conferences

May 18, 2017 8:00am EDT

Recro Pharma Presents Phase III Bunionectomy Clinical Data for IV Meloxicam at the American Pain Society 36th Annual Scientific Meeting

May 15, 2017 7:00am EDT

Recro Pharma to Present Phase III Bunionectomy Clinical Data for IV Meloxicam at the American Pain Society 36th Annual Scientific Meeting

May 11, 2017 7:00am EDT

Recro Pharma Reports First Quarter 2017 Financial Results

May 09, 2017 7:00am EDT

Recro Pharma Announces Successful Top-Line Results from Phase III Safety Study of IV Meloxicam

Mar 29, 2017 7:00am EDT

Recro Pharma to Present at the 16th Annual Needham Healthcare Conference

Mar 16, 2017 7:00am EDT

Recro Pharma to Present at the Oppenheimer 27th Annual Healthcare Conference

  • Previous Pagearrow_back
  • Page 1
  • …
  • Page 12
  • Page 13
  • Page 14
  • Page 15
  • Page 16
  • Page 17
  • Page 18
  • Page 19
  • Page 20
  • Page 21
  • …
  • Page 24
  • Next Pagearrow_forward
rss_feed News RSS
  • Email Alerts
  • Contacts
  • RSS News Feed
  • Privacy Policy
  • Terms & Conditions
  • Disclaimer
Copyright ©2023 Societal CDMO. All rights reserved. Manage Cookie Preferences
Follow us